mebeverine

Known as: 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate, duspatalin, spasmotalin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1963-2017
051019632017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND The 5-HT(3) receptor antagonists are known to be effective for the treatment of diarrhea-predominant irritable bowel… (More)
Is this relevant?
2009
2009
Mebeverine hydrochloride is known to suffer from extensive first pass effect. In an attempt to improve its oral bioavailability… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2006
2006
The anti-spasmodic drug mebeverine is used in the treatment of irritable bowel syndrome. It has been found to be unstable and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
Is this relevant?
2005
2005
OBJECTIVE To assess the efficacy of cognitive behaviour therapy delivered in primary care for treating irritable bowel syndrome… (More)
Is this relevant?
2004
2004
BACKGROUND Irritable bowel syndrome (IBS) is a functional disorder affecting the quality of life of patients. In the Netherlands… (More)
Is this relevant?
2002
2002
The intestinal spasmolytic drug mebeverine is known to undergo fast in vivo enzymatic hydrolysis into mebeverine alcohol and… (More)
Is this relevant?
1999
1999
BACKGROUND Irritable bowel syndrome is one of the most common gastrointestinal disorders, yet no therapy convincingly controls… (More)
Is this relevant?
1996
1996
BACKGROUND AND AIM Despite its widespread use in irritable bowel syndrome (IBS), limited clinical data exist on the effects of… (More)
Is this relevant?
1991
1991
The HPLC methods for the determination of plasma concentrations of the antispasmodic agent mebeverine (0.01-10 micrograms/mL) and… (More)
Is this relevant?
1986
1986
There is no generally accepted treatment in the irritable bowel syndrome (IBS), probably because of a lack of convincing… (More)
Is this relevant?